11:10 AM EST, 12/11/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were on the rise late Thursday morning, increasing 0.82% to 1,663.66 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion ( EVAX ) and biopharmaceutical firm Cellectis ( CLLS ) , which rose 4.6% and 3.9%, respectively. They were followed by telecommunications company Nokia ( NOK ) and pharmaceutical firm Novo Nordisk ( NVO ) , which advanced 3.6% and 2.6% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and medical device maker EDAP TMS ( EDAP ) , which fell 3.8% and 1.7% respectively. They were followed by oil and gas company Eni (E) and petroleum refiner Equinor ( EQNR ) , which were off 0.2% each.

From the UK and Ireland, the gainers were led by cruise line operator Carnival (CUK) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which increased 4% and 3.4% respectively. They were followed by communications company WPP ( WPP ) and alcoholic beverage company Diageo ( DEO ) , which were up 3% each.

The decliners from the UK and Ireland were led by biopharmaceutical firms Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which dropped 8.7% and 3%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and medical device manufacturer Smith & Nephew ( SNN ) , which lost 1.9% and 1.7% respectively.